Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371941 · ClinicalTrials.gov registry record · Phase 4
Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
A Phase 4 study of Eosinophilic Esophagitis, sponsored by University of Tennessee.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02371941 is a Phase 4 study of Eosinophilic Esophagitis that has completed, run by University of Tennessee. The registered enrollment target is 16 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02371941, a Phase 4 study of Eosinophilic Esophagitis, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double-blind, placebo-controlled study of oral cromolyn sodium when made into a viscous preparation for the treatment of eosinophilic esophagitis.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG oral cromolyn sodium
Study Locations (1)
Tennessee
- LeBonheur Children's Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371941
The ClinicalTrials.gov registry entry for NCT02371941 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (98% lower). The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02371941 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02371941 about?
NCT02371941 is a clinical study titled "Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis". This is a randomized, double-blind, placebo-controlled study of oral cromolyn sodium when made into a viscous preparation for the treatment of eosinophilic esophagitis.
What is the current status of trial NCT02371941?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2014-12. Estimated completion is 2017-12.
What conditions does trial NCT02371941 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis.
What interventions are being tested in trial NCT02371941?
The interventions under investigation include: Placebo (DRUG), oral cromolyn sodium (DRUG).
Who is sponsoring clinical trial NCT02371941?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02371941 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)
ACTIVE NOT RECRUITING · Phase 4
-
Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis
COMPLETED · Phase 4
-
Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)
RECRUITING
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Registry for the Food Allergy Community
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.